TriSalus Life Sciences, Inc. (TLSI) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

Earnings Reports

• Trisalis Life Sciences (TLSI) Q1 2026: PEDD Study Delivers $7,700 Per Patient Cost Avoidance, Driving Platform Validation
  May 13, 2026
• Trisalis Life Sciences (TLSI) Q3 2025: Mapping Drives 30% of Growth as TriNav Platform Broadens Clinical Reach
  November 14, 2025
• Trisalis Life Sciences (TLSI) Q2 2025: TriNavFlex Launch Fuels 52% Revenue Surge and Expands Clinical Reach
  August 12, 2025

Browse all companies